Managing Fatigue in Patients With Interstitial Lung Disease
| Autor: | Catharina C. Moor, Vivienne Kahlmann, Marlies S. Wijsenbeek |
|---|---|
| Přispěvatelé: | Pulmonary Medicine |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
Adult Male medicine.medical_specialty FAS fatigue assessment scale Tailored approach Psychological intervention Critical Care and Intensive Care Medicine 03 medical and health sciences Idiopathic pulmonary fibrosis 0302 clinical medicine Quality of life (healthcare) Multidisciplinary approach medicine IPF idiopathic pulmonary fibrosis Humans In patient 030212 general & internal medicine Intensive care medicine Fatigue business.industry sIL-2R soluble IL-2 receptor (sIL-2R) Interstitial lung disease Treatment options Disease Management medicine.disease Diffuse Lung Disease: How I Do It QoL quality of life 030228 respiratory system Quality of Life ILD interstitial lung disease Cardiology and Cardiovascular Medicine business Lung Diseases Interstitial |
| Zdroj: | Chest, 158(5), 2026-2033. American College of Chest Physicians Chest |
| ISSN: | 1931-3543 0012-3692 |
| Popis: | Fatigue is one of the most burdensome symptoms in interstitial lung disease (ILD) and can have a major impact on quality of life, social interactions, and work capacity. The cause of fatigue is complex; it is caused or aggravated by a combination of different predisposing, precipitating, and perpetuating factors. There is no uniform definition of fatigue, but it is often divided in physical and mental components. Several validated questionnaires can be used for structural assessment of fatigue in daily care. Although the high burden of fatigue in ILD is recognized increasingly, studies that have investigated pharmacologic and nonpharmacologic treatment options are scarce. Because fatigue in ILD is often a multifactorial problem, therapeutic interventions ideally should be aimed at different domains. One of the first steps is to optimize treatment of the underlying disease. Subsequently, treatable causes of fatigue should be identified and treated. Recently, an increasing number of studies showed that supportive measures have the potential to improve fatigue. However, evidence-based treatment guidelines are lacking, and more research is highly needed in this field. In clinical practice, a comprehensive, multidisciplinary, and individually tailored approach seems best fit to optimize treatment of fatigue in patients with ILD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|